Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 4808046, 10 pages
https://doi.org/10.1155/2018/4808046
Research Article

Combination of Genetic Markers and Age Effectively Facilitates the Identification of People with High Risk of Preeclampsia in the Han Chinese Population

1Shenzhen Maternal and Child Health Care Hospital Affiliated to Southern Medical University, China
2Department of Cell Biology and Genetics, Shenzhen University Health Science Center, China
3Department of Immunology and Internal Rheumatics in Children’s Hospital of Anhui Province, China
4Laboratory Department, Shenzhen Maternal and Child Health Hospital Affiliated to Southern Medical University, China

Correspondence should be addressed to Yejun Wang; nc.ude.uzs@jygnaw

Received 14 March 2018; Revised 15 May 2018; Accepted 11 June 2018; Published 19 July 2018

Academic Editor: Momiao Xiong

Copyright © 2018 Lu Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Duley, “The global impact of pre-eclampsia and eclampsia,” Seminars in Perinatology, vol. 33, no. 3, pp. 130–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Steegers, P. von Dadelszen, J. J. Duvekot, and R. Pijnenborg, “Pre-eclampsia,” The Lancet, vol. 376, no. 9741, pp. 631–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Chaiworapongsa, P. Chaemsaithong, L. Yeo, and R. Romero, “Pre-eclampsia part 1: Current understanding of its pathophysiology,” Nature Reviews Nephrology, vol. 10, no. 8, pp. 466–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” The Lancet, vol. 365, no. 9461, pp. 785–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Noris, N. Perico, and G. Remuzzi, “Mechanisms of disease: pre-eclampsia,” Nature Clinical Practice Nephrology, vol. 1, no. 2, pp. 98–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Granger, B. T. Alexander, M. T. Llinas, W. A. Bennett, and R. A. Khalil, “Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction,” Hypertension, vol. 38, no. 3, pp. 718–722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Lyall, S. C. Robson, and J. N. Bulmer, “Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction relationship to clinical outcome,” Hypertension, vol. 62, no. 6, pp. 1046–1054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. W. G. Redman and I. L. Sargent, “Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review,” Placenta, vol. 24, pp. S21–S27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Buurma, R. J. Turner, J. H. M. Driessen et al., “Genetic variants in pre-eclampsia: A meta-analysis,” Human Reproduction Update, vol. 19, no. 3, Article ID dms060, pp. 289–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Morgan, R. McGinnis, V. Steinthorsdottir et al., “InterPregGen: Genetic studies of pre-eclampsia in three continents,” Norsk epidemiologi, vol. 24, no. 1-2, pp. 141–146, 2014. View at Google Scholar · View at Scopus
  11. G. Tuteja, E. Cheng, H. Papadakis, and G. Bejerano, “PESNPdb: a comprehensive database of SNPs studied in association with pre-eclampsia,” Placenta, vol. 33, no. 12, pp. 1055–1057, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. National Collaborating Centre for Women’s and Children’s Health (UK), Antenatal Care: Routine Care for the Healthy Pregnant Woman, RCOG Press, London, UK, 2008.
  13. F. Milne, C. Redman, J. Walker et al., “Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II).,” BMJ (Clinical research ed.), vol. 339, p. b3129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Mizuno, S. Ogishima, H. Nishigori et al., “The pre-eclampsia ontology: A disease ontology representing the domain knowledge specific to pre-eclampsia,” PLoS ONE, vol. 11, no. 10, 2016. View at Google Scholar · View at Scopus
  15. C. Briceo-Prez, L. Briceo-Sanabria, and P. Vigil-De Gracia, “Prediction and prevention of preeclampsia,” Hypertension in Pregnancy, vol. 28, no. 2, pp. 138–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Dekker and B. Sibai, “Primary, secondary, and tertiary prevention of pre-eclampsia,” The Lancet, vol. 357, no. 9251, pp. 209–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Von Dadelszen and L. A. Magee, “Pre-eclampsia: An Update,” Current Hypertension Reports, vol. 16, no. 8, article no. 454, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Verghese, S. Alam, S. Beski, R. Thuraisingham, I. Barnes, and P. MacCallum, “Antenatal screening for pre-eclampsia: Evaluation of the NICE and pre-eclampsia community guidelines,” Journal of Obstetrics & Gynaecology, vol. 32, no. 2, pp. 128–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Liu, Y. Li, Y. Yao et al., “Polymorphisms of the IL27 gene in a Chinese Han population complicated with pre-eclampsia,” Scientific Reports, vol. 6, Article ID 23029, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. B. A. G. Marwa, N. Raguema, H. Zitouni et al., “FGF1 and FGF2 mutations in preeclampsia and related features,” Placenta, vol. 43, pp. 81–85, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Chaiworapongsa, P. Chaemsaithong, S. J. Korzeniewski, L. Yeo, and R. Romero, “Pre-eclampsia part 2: Prediction, prevention and management,” Nature Reviews Nephrology, vol. 10, no. 9, pp. 531–540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Gao, C. Liu, P. Lin et al., “Effects of GSTP1 and GPX1 Polymorphisms on the Risk of Preeclampsia in Chinese Han Women,” Cellular Physiology and Biochemistry, vol. 39, no. 5, pp. 2025–2032, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Zhou, L. Cheng, Y. He, Y. Gu, Y. Wang, and C. Wang, “Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women,” Inflammation Research, vol. 65, no. 9, pp. 717–724, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. ACOG Committee on Practice Bulletins—Obstetrics, “ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia,” Obstetrics & Gynecology, vol. 99, no. 1, pp. 159–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. I. S. Hoffmann, R. Tavares-Mordwinkin, A. M. Castejon, A. B. Alfieri, and L. X. Cubeddu, “Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics,” Journal of Human Hypertension, vol. 19, no. 3, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Shanmugam, K. W. Sell, and B. K. Saha, “Mistyping ACE heterozygotes,” Genome Research, vol. 3, no. 2, pp. 120-121, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Hui, Y. Hu, M. Sun et al., “EBT: a statistic test identifying moderate size of significant features with balanced power and precision for genome-wide rate comparisons,” Bioinformatics, vol. 33, no. 17, pp. 2631–2641, 2017. View at Publisher · View at Google Scholar
  28. L. W. Hahn, M. D. Ritchie, and J. H. Moore, “Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions,” Bioinformatics, vol. 19, no. 3, pp. 376–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. “Group of Obstetrics and Gynecology branch of Chinese Medical Association of hypertensive disorders in pregnancy: Guidelines for diagnosis and treatment of hypertensive disorder complicating pregnancy,” Chin J Obstet Gynecol, vol. 50, pp. 721–728, 2015.
  30. H. Choi, J. Y. Kang, H. S. Yoon et al., “Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia,” Journal of Korean Medical Science, vol. 19, no. 2, pp. 253–257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. B. Pinheiro, K. B. Gomes, C. R. S. C. Ronda et al., “Severe preeclampsia: Association of genes polymorphisms and maternal cytokines production in Brazilian population,” Cytokine, vol. 71, no. 2, pp. 232–237, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Daher, N. Sass, L. G. Oliveira, and R. Mattar, “Cytokine genotyping in preeclampsia,” American Journal of Reproductive Immunology, vol. 55, no. 2, pp. 130–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Sowmya, A. Ramaiah, T. Sunitha, P. Nallari, A. Jyothy, and A. Venkateshwari, “Evaluation of interleukin-10 (G-1082A) promoter polymorphism in preeclampsia,” Journal of Reproduction and Infertility, vol. 14, no. 2, pp. 62–66, 2013. View at Google Scholar · View at Scopus
  34. E. Y. Valencia Villalvazo, T. Canto-Cetina, J. F. Romero Arauz et al., “Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 11, pp. 1263–1269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Kamali-Sarvestani, S. Kiany, B. Gharesi-Fard, and M. Robati, “Association study of IL-10 and IFN-γ gene polymorphisms in Iranian women with preeclampsia,” Journal of Reproductive Immunology, vol. 72, no. 1-2, pp. 118–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Freeman, F. McManus, E. A. Brown et al., “Short- and long-term changes in plasma inflammatory markers associated with preeclampsia,” Hypertension, vol. 44, no. 5, pp. 708–714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Molvarec, Á. Jermendy, B. Nagy et al., “Association between tumor necrosis factor (TNF)-α G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction,” Clinica Chimica Acta, vol. 392, no. 1-2, pp. 52–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Pazarbasi, M. Kasap, and A. I. Guzel, “Polymorphisms in the tumor necrosis factor-alpha gene in Turkish women with pre-eclampsia and eclampsia,” Acta Med Okayama, vol. 61, no. 3, pp. 153–160, 2007. View at Google Scholar
  39. T. Canto-Cetina, S. Canizales-Quinteros, E. De La Chesnaye, R. Coral-Vázquez, J. P. Méndez, and P. Canto, “Analysis of C-850T and G-308A polymorphisms of the tumor necrosis factor-α gene in Maya-Mestizo women with preeclampsia,” Hypertension in Pregnancy, vol. 26, no. 3, pp. 283–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. O. Galão, L. H. De Souza, B. E. Pinheiro Da Costa, R. M. Scheibe, and C. E. Poli De Figueiredo, “Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy,” American Journal of Obstetrics & Gynecology, vol. 191, no. 3, pp. 821–824, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. F. Lewis, B. J. Canzoneri, and Y. Wang, “ORIGINAL ARTICLE: Maternal Circulating TNF-α Levels are Highly Correlated with IL-10 Levels, but not IL-6 and IL-8 Levels, in Women with Pre-Eclampsia,” American Journal of Reproductive Immunology, vol. 62, no. 5, pp. 269–274, 2009. View at Publisher · View at Google Scholar